The 2007 WHO ClassiWcation of Tumours of the Central Nervous System
暂无分享,去创建一个
Webster K. Cavenee | David N. Louis | Anne Jouvet | B. Scheithauer | D. Louis | P. Kleihues | H. Ohgaki | O. Wiestler | W. Cavenee | P. Burger | A. Jouvet | Hiroko Ohgaki | Peter C. Burger | Paul Kleihues | Otmar D. Wiestler | Bernd W. Scheithauer
[1] E. Zackai,et al. Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994. , 1997, The Journal of pediatrics.
[2] J. Vermeesch,et al. Preimplantation genetic diagnosis using fluorescent in situ hybridization for cancer predisposition syndromes caused by microdeletions. , 2009, Human reproduction.
[3] T. Tamiya,et al. Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas , 2000, Neuroradiology.
[4] P. Black,et al. The prognostic significance of postoperative residual tumor in ependymoma. , 1991, Neurosurgery.
[5] A. Tsirikos,et al. Spinal deformity in neurofibromatosis type-1: diagnosis and treatment , 2005, European Spine Journal.
[6] S. Pomeroy,et al. Pediatric brain tumors. , 2003, Neurologic clinics.
[7] H. Hameister,et al. An isochore transition zone in the NF1 gene region is a conserved landmark of chromosome structure and function. , 2005, Genomics.
[8] N. Ringertz. Grading of gliomas. , 2009 .
[9] B. Scheithauer,et al. Intraventricular perineurioma: case report. , 1998, Neurosurgery.
[10] M. Santi,et al. Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors. , 2003, The oncologist.
[11] I. Jacobs,et al. Management of head and neck plexiform neurofibromas in pediatric patients with neurofibromatosis type 1. , 2005, Archives of otolaryngology--head & neck surgery.
[12] X. Estivill,et al. Prenatal diagnosis of sporadic neurofibromatosis type 1 (NF1) by RNA and DNA analysis of a splicing mutation , 1999, Prenatal diagnosis.
[13] R. Garcea,et al. SV40 and human brain tumors. , 1997, Journal of neurovirology.
[14] D. Louis,et al. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. , 1997, Annals of neurology.
[15] S. Donaldson,et al. Astrocytoma in children: 14 years' experience at Stanford University Medical Center. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Bonnin,et al. Tumors of the Central Nervous System (I) , 1988 .
[17] P. Liberski,et al. Chromosomal alterations in a case of ganglioglioma. , 1995, Cancer genetics and cytogenetics.
[18] A. von Deimling,et al. Malignant transformation of a gangliocytoma/ganglioglioma into a glioblastoma multiforme: a molecular genetic analysis. Case report. , 2001, Journal of neurosurgery.
[19] K. Aldape,et al. Small cell astrocytoma: An aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma , 2004, Cancer.
[20] B. Brownstein,et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. , 1990, Science.
[21] L. Becker,et al. Infratentorial ependymomas in childhood: prognostic factors and treatment. , 1990, Journal of neurosurgery.
[22] K. Hamano,et al. Aicardi syndrome accompanied by auditory disturbance and multiple brain tumors , 1991, Brain and Development.
[23] P. Kleihues,et al. More about: cell and molecular biology of simian virus 40: implications for human infections and disease. , 2000, Journal of the National Cancer Institute.
[24] L. Kihlström,et al. Stereotactic radiosurgery for tectal low-grade gliomas. , 1994, Acta neurochirurgica. Supplement.
[25] M. Rosenblum,et al. Monomorphous Angiocentric Glioma: A Distinctive Epileptogenic Neoplasm With Features of Infiltrating Astrocytoma and Ependymoma , 2005, Journal of neuropathology and experimental neurology.
[26] P. Gerszten,et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. , 1995, Neurosurgery.
[27] Roger E. Taylor,et al. Radiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts. , 2002, Medical and pediatric oncology.
[28] A. Spiotta,et al. Experimental therapeutic approaches to peripheral nerve tumors. , 2007, Neurosurgical focus.
[29] R. McLendon,et al. MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. , 2002, Archives of pathology & laboratory medicine.
[30] F. Giangaspero,et al. Ependymoma with neuropil-like islands: a case report with diagnostic and histogenetic implications , 2005, Acta Neuropathologica.
[31] Thomas Klockgether,et al. Molecular genetic alterations in glioblastomas with oligodendroglial component , 2001, Acta Neuropathologica.
[32] R. Garcea,et al. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. , 1995, Virology.
[33] P. Devroey,et al. Preimplantation genetic diagnosis for neurofibromatosis type 1. , 2005, Molecular human reproduction.
[34] J. Trojanowski,et al. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] K. Aldape,et al. Small Cell Architecture—A Histological Equivalent of EGFR Amplification in Glioblastoma Multiforme? , 2001, Journal of neuropathology and experimental neurology.
[36] C. Miller,et al. Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] K. North,et al. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. , 2004, Ophthalmology.
[38] A. von Deimling,et al. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1 , 2001, Acta Neuropathologica.
[39] M. Berger,et al. Intracranial Ependymomas of Childhood: Current Management Strategies , 2000, Pediatric Neurosurgery.
[40] Thomas E Merchant,et al. Preliminary results from a Phase II trail of conformal radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma. , 2002, International journal of radiation oncology, biology, physics.
[41] R. Friedrich,et al. Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1. , 2007, Anticancer research.
[42] L. Rorke,et al. Prognostic factors in childhood ependymomas. , 1990, Pediatric neurosurgery.
[43] A. Probst,et al. [Ganglioglioma of optic nerve in neurofibromatosis type 1. Case report and review of the literature]. , 2000, Klinische Monatsblatter fur Augenheilkunde.
[44] L. Riffaud,et al. Supratentorial Ependymoma in Children , 2001, Pediatric Neurosurgery.
[45] L. Rorke,et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. , 1994, Journal of neurosurgery.
[46] J L Kepner,et al. Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. , 1998, The American journal of surgical pathology.
[47] J. Nakayama,et al. Treatment of pigmented lesions of neurofibromatosis 1 with intense pulsed–radio frequency in combination with topical application of vitamin D3 ointment , 2007, The Journal of dermatology.
[48] V. Jay,et al. Intracranial and spinal metastases from a ganglioglioma with unusual cytogenetic abnormalities in a patient with complex partial seizures , 1997, Child's Nervous System.
[49] J. Blasko,et al. Cystic cerebellar astrocytomas in childhood , 1979, Cancer.
[50] D. Ho,et al. Oligodendroglioma occurring after radiation therapy for pituitary adenoma. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[51] Ulrich Hubbe,et al. Perspectives and limitations of image-guided neurosurgery in pediatric patients , 2003, Child's Nervous System.
[52] C. Lázaro,et al. Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations , 2008, Human mutation.
[53] D. Brat,et al. Pituicytoma: Report of Two Cases and Clues Regarding Histogenesis , 2004, Neurosurgery.
[54] L. Neder,et al. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study. , 2004, Clinical neuropathology.
[55] D. Schiffer,et al. Prognosis of ependymoma , 1998, Child's Nervous System.
[56] R. Grossman,et al. The Clinical Significance of Extracellular Matrix in Gangliogliomas , 1996, Journal of neuropathology and experimental neurology.
[57] E. Haan,et al. SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype , 2009, Journal of Medical Genetics.
[58] J. Biegel,et al. Molecular cytogenetic studies of pediatric ependymomas , 1998, Journal of Neuro-Oncology.
[59] G. Mortier,et al. Whole body MR imaging in neurofibromatosis type 1 , 2009 .
[60] J. Østergaard,et al. Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6 , 2005, American journal of medical genetics. Part A.
[61] T. van Dyke,et al. Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen , 1994, Molecular and cellular biology.
[62] G. Basso,et al. Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamic‐optic chiasm region , 1997, Cancer.
[63] W Krone,et al. An isochore transition in the NF1 gene region coincides with a switch in the extent of linkage disequilibrium. , 2000, American journal of human genetics.
[64] J. Biegel,et al. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood , 2005, Journal of Neuro-Oncology.
[65] R. Folkerth,et al. Evidence for clonal origin of neoplastic neuronal and glial cells in gangliogliomas. , 1997, The American journal of pathology.
[66] G. Utermann,et al. Hypomelanosis of Ito in a girl with plexus papilloma and translocation (X;17) , 1993, Human Genetics.
[67] B. Harris,et al. Spinal cord glioneuronal tumor with “rosetted” neuropil islands and meningeal dissemination: a case report , 2000, Acta Neuropathologica.
[68] R. Gibbs,et al. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1. , 2006, Biochemical pharmacology.
[69] F. Collins,et al. The neurofibromatosis type 1 gene and its protein product, neurofibromin , 1993, Neuron.
[70] R. Siebert,et al. Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene , 2004, Human mutation.
[71] F. Saran. Recent advances in paediatric neuro-oncology , 2002, Current opinion in neurology.
[72] P. Kleihues,et al. Cerebellar medullomyoblastoma with advanced neuronal differentiation and hamartomatous component , 2004, Acta Neuropathologica.
[73] X. Estivill,et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. , 2000, Human molecular genetics.
[74] A. Lee,et al. Neuroophthalmological management of optic pathway gliomas. , 2007, Neurosurgical focus.
[75] D. Figarella-Branger,et al. Pilocytic Astrocytomas in Children: Prognostic Factors—A Retrospective Study of 80 Cases , 2003, Neurosurgery.
[76] K. Murray,et al. Importance of histologic condition and treatment of pediatric cerebellar astrocytoma , 1991 .
[77] M. Souweidane,et al. Prolonged Convection-enhanced Delivery into the Rat Brainstem , 2003, Neurosurgery.
[78] I. Pollack,et al. High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. , 1996, Neurosurgery.
[79] D. Schiffer,et al. Medullomyoblastoma: report of two cases , 1992, Child's Nervous System.
[80] B. Scheithauer,et al. `Spindle Cell Oncocytoma' of the Adenohypophysis: A Tumor of Folliculostellate Cells? , 2002, The American journal of surgical pathology.
[81] V. Blair,et al. Radiotherapy in the treatment of low-grade astrocytomas , 1995, Child's Nervous System.
[82] S. Bertolone,et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] O. Delattre,et al. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. , 1999, American journal of human genetics.
[84] E. Bouffet,et al. Chemotherapy for intracranial ependymomas , 1999, Child's Nervous System.
[85] L. Rorke,et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[86] A. Perry,et al. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features. , 2001, Journal of neurosurgery.
[87] M. Nöthen,et al. A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas. , 1997, Journal of neuropathology and experimental neurology.
[88] K. Poskitt,et al. Duplication of 9P and hyperplasia of the choroid plexus: a pathologic, radiologic, and molecular cytogenetics study. , 1995, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.
[89] P. Cogen,et al. Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system. , 1997, Cancer genetics and cytogenetics.
[90] L. Rorke,et al. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[91] Zbigniew Petrovich,et al. THE CYBERKNIFE STEREOTACTIC RADIOSURGERY SYSTEM: DESCRIPTION, INSTALLATION, AND AN INITIAL EVALUATION OF USE AND FUNCTIONALITY , 2008, Neurosurgery.
[92] J. Squire,et al. MALIGNANT TRANSFORMATION IN A GANGLIOGLIOMA WITH ANAPLASTIC, NEURONAL AND ASTROCYTIC COMPONENTS: REPORT OF A CASE WITH FLOW CYTOMETRIC AND CYTOGENETIC ANALYSIS , 1993 .
[93] J. Drake,et al. Massive plexiform neurofibromas in childhood: natural history and management issues. , 2007, Journal of neurosurgery.
[94] I. Ezpeleta,et al. [Melanotic medulloblastoma. Ultrastructural and histochemical study of a case]. , 1990, Archivos de neurobiologia.
[95] T. Ekfors,et al. Pigmented primitive neuroectodermal tumor with multipotential differentiation in cerebellum (pigmented medullomyoblastoma). A case with light- and electron-microscopic, and immunohistochemical analysis. , 1987, Pediatric neuroscience.
[96] R. McLendon,et al. Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. , 1998, The American journal of surgical pathology.
[97] R. Garcea,et al. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. , 1992, The New England journal of medicine.
[98] M E Cohen,et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. , 1993, The New England journal of medicine.
[99] C. Fuller,et al. Medullomyoblastoma: A radiographic and clinicopathologic analysis of six cases and review of the literature , 2004, Cancer.
[100] P. Burger,et al. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. , 1999, Journal of neuropathology and experimental neurology.
[101] V. Esposito,et al. Radiosurgery in the management of pediatric brain tumors , 2000, Child's Nervous System.
[102] S. Pinson,et al. [Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1]. , 2007, Annales de dermatologie et de venereologie.
[103] M. Prados,et al. Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. , 1994, Journal of neurosurgery.
[104] A. Hoischen,et al. Angiocentric Glioma: Report of Clinico-Pathologic and Genetic Findings in 8 Cases , 2007, The American journal of surgical pathology.
[105] Felice Giangaspero,et al. Atypical Teratoid/Rhabdoid Tumors and Choroid Plexus Tumors: When Genetics “Surprise” Pathology , 2003, Brain pathology.
[106] M. Hirose,et al. Rhabdoid tumor of the kidney: a report of two cases with respective tumor markers and a specific chromosomal abnormality, del(11p13). , 1996, Medical and pediatric oncology.
[107] J. Farmer,et al. Pediatric brain stem gliomas: a review. , 1998, International journal of radiation oncology, biology, physics.
[108] J. Wisoff,et al. The impact of extent of resection in the management of malignant gliomas of childhood , 1999, Child's Nervous System.
[109] J. Charrow,et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. , 1994, The Journal of pediatrics.
[110] R. Perry,et al. Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. , 1995, British Journal of Cancer.
[111] A. Jouvet,et al. Papillary Tumor of the Pineal Region , 2003, The American journal of surgical pathology.
[112] G Mortier,et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects , 2000, Human mutation.
[113] James R. Anderson,et al. Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study. , 1996, Medical and pediatric oncology.
[114] K. Hoang-Xuan,et al. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. , 1999, Human molecular genetics.
[115] X. Estivill,et al. Molecular characterization of the breakpoints of a 12-kb deletion in the NF1 gene in a family showing germ-line mosaicism. , 1995, American journal of human genetics.
[116] X. Estivill,et al. Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients , 2003, Journal of medical genetics.
[117] I. Vajtai,et al. Spindle cell oncocytoma of the adenohypophysis: report of a case with a 16-year follow-up. , 2006, Pathology, research and practice.
[118] L. Rorke,et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[119] D. Seidenwurm,et al. Angiocentric Neuroepithelial Tumor (ANET): A New Epilepsy‐Related Clinicopathological Entity with Distinctive MRI , 2005, Brain pathology.
[120] A. Olivi,et al. Pilocytic and Pilomyxoid Hypothalamic/Chiasmatic Astrocytomas , 2004, Neurosurgery.
[121] A. Nirenberg,et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/Primitive neuroectodermal tumors , 1997, Cancer.
[122] P. Marynen,et al. Encephalocraniocutaneous lipomatosis with a mutation in the NF1 gene. , 1995, Journal of medical genetics.
[123] I. Pollack. Brain tumors in children. , 1994, The New England journal of medicine.
[124] A P Warrington,et al. Design and implementation of a system for treating paediatric patients with stereotactically-guided conformal radiotherapy. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[125] L. Palma,et al. The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases. , 2000, Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery.
[126] M. O'Doherty,et al. [18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[127] A. Menezes,et al. Three Choroid Plexus Papillomas in a Patient with Aicardi Syndrome , 2000, Pediatric Neurosurgery.
[128] B. Rilliet,et al. Gliomas in children: a review , 2000, Child's Nervous System.
[129] M. O'Doherty,et al. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[130] S. Franceschi,et al. Correlation Among Pathology, Genotype, and Patient Outcomes in Glioblastoma , 2006, Journal of neuropathology and experimental neurology.
[131] Tracey A. Cho,et al. Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. , 1999, Cancer research.
[132] S. Lowe,et al. p53-Dependent apoptosis suppresses tumor growth and progression in vivo , 1994, Cell.
[133] C. L. Dolman. Melanotic medulloblastoma , 2004, Acta Neuropathologica.
[134] Daniel H. Kim,et al. Neurofibromatosis-associated nerve sheath tumors. Case report and review of the literature. , 2006, Neurosurgical focus.
[135] A. Urgesi,et al. Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. , 2001, International journal of radiation oncology, biology, physics.
[136] R. Lehmann,et al. Two independent mutations in a family with neurofibromatosis type 1 (NF1). , 1999, American journal of medical genetics.
[137] J. Biegel,et al. Narrowing the critical region for a rhabdoid tumor locus in 22q11 , 1996, Genes, chromosomes & cancer.
[138] E. Pasmant,et al. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype , 2009, Journal of Medical Genetics.
[139] H. Kehrer-Sawatzki,et al. Spectrum of single‐ and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients , 2006, Genes, chromosomes & cancer.
[140] H. Bloom,et al. Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. , 1992, International journal of radiation oncology, biology, physics.
[141] S. Giustini,et al. Role of Maxillofacial Surgery in Patients With Neurofibromatosis Type I , 2007, The Journal of craniofacial surgery.
[142] J. Biegel,et al. Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain. , 1989, The New England journal of medicine.
[143] J. Biegel,et al. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. , 1996, Journal of neurosurgery.
[144] P. Kelly,et al. Posterior fossa ependymomas: report of 30 cases and review of the literature. , 1991, Neurosurgery.
[145] T. de Ravel,et al. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. , 2009, The Lancet. Oncology.
[146] B. Scheithauer,et al. The New WHO Classification of Brain Tumours , 1993, Brain pathology.
[147] Daniel H. Kim,et al. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center. , 2005, Journal of neurosurgery.
[148] J. Drake,et al. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. , 2000, American journal of human genetics.
[149] M. Rosenblum,et al. High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[150] P. O'Connell,et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations , 1990, Cell.
[151] Olivier Delattre,et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer , 1998, Nature.
[152] M. Mizuguchi,et al. Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis , 2003, Acta Neuropathologica.
[153] P. Steinbok. Management and outcome of low-grade astrocytomas of the midline in children: A retrospective review. , 1994, Neurosurgery.
[154] G. Reifenberger,et al. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. , 1999, The American journal of pathology.
[155] P. Kleihues,et al. Astrocytomas and Choroid Plexus Tumors in Two Families with Identical p53 Germline Mutations , 1998, Journal of neuropathology and experimental neurology.
[156] Hiroyuki Yoshida,et al. Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images. , 2009, Radiology.
[157] K. Yohay. The genetic and molecular pathogenesis of NF1 and NF2. , 2006, Seminars in pediatric neurology.
[158] V. Levin,et al. Management of hypothalamic gliomas in children: an analysis of 33 cases. , 1990, Neurosurgery.
[159] J. Marks,et al. Childhood cerebellar astrocytomas: is there a role for postoperative irradiation? , 1990, International journal of radiation oncology, biology, physics.
[160] R. Packer,et al. Chemotherapy for low-grade gliomas , 1999, Child's Nervous System.
[161] J. Drake,et al. Development of anaplastic changes in low-grade astrocytomas of childhood. , 1994, Neurosurgery.
[162] D. Louis,et al. Spindle cell oncocytoma of the adenohypophysis: report of two cases , 2005, Acta Neuropathologica.
[163] Jianxiong Shen,et al. Surgical treatment of scoliosis caused by neurofibromatosis type 1. , 2005, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.
[164] R. Weksberg,et al. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. , 2004, Gastroenterology.
[165] J. Graham,et al. Microphthalmia and chorioretinal lesions in a girl with an Xp22.2-pter deletion and partial 3p trisomy: clinical observations relevant to Aicardi syndrome gene localization. , 1990, American journal of medical genetics.
[166] D. Brat,et al. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. , 2001, The American journal of pathology.
[167] D. Brat,et al. Pituicytoma: a distinctive low-grade glioma of the neurohypophysis. , 2000, The American journal of surgical pathology.
[168] H. Pass,et al. Simian virus 40, poliovaccines and human tumors: a review of recent developments , 1997, Oncogene.
[169] R. Cawthon,et al. The neurofibromatosis type 1 gene. , 1993, Annual review of neuroscience.
[170] A. King,et al. Optic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome , 2003, American journal of medical genetics. Part A.
[171] D. Dickson,et al. Medulloblastoma with Glial and Rhabdomyoblastic Differentiation A Myoglobin and Glial Fibrillary Acidic Protein Immunohistochemical and Ultrastructural Study , 1983, Journal of neuropathology and experimental neurology.
[172] D. Brat,et al. Newly Codified Glial Neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: Angiocentric Glioma, Pilomyxoid Astrocytoma and Pituicytoma , 2007, Brain pathology.
[173] J. Bruner,et al. Intracranial ependymoma in children: analysis of prognostic factors , 1992, Journal of Neuro-Oncology.
[174] S. Elledge,et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease , 2003, Nature Genetics.
[175] W F Taylor,et al. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. , 1984, Journal of neurosurgery.
[176] A. Monaco,et al. Characterisation of X; 17(q12;p 13) Translocation Breakpoints in a Female Patient with Hypomelanosis of Ito and Choroid Plexus Papilloma , 1997, European journal of human genetics : EJHG.
[177] R. Kortmann,et al. Preradiation chemotherapy for pediatric patients with high‐grade glioma , 2002, Cancer.
[178] B. Scheithauer,et al. A Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle: Infratentorial Form of Dysembryoplastic Neuroepithelial Tumor? , 2002, The American journal of surgical pathology.
[179] I. Pollack,et al. Chemotherapy for high-grade gliomas of childhood , 1999, Child's Nervous System.
[180] Thomas W. Smith,et al. Medullomyoblastoma. A histologic, immunohistochemical, and ultrastructural study , 1984, Cancer.
[181] S. G. Cheng,et al. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function , 1999, Nature Genetics.
[182] H. Budka,et al. Rosette-forming glioneuronal tumor of the fourth ventricle , 2003, Acta Neuropathologica.
[183] M. Jennings,et al. Pharmacotherapy of Malignant Astrocytomas of Children and Adults , 2001, CNS drugs.
[184] R. Lehmann,et al. Recurrent NF1 gene mutation in a patient with oligosymptomatic neurofibromatosis type 1 (NF1). , 1999, American journal of medical genetics.
[185] J. Zeller,et al. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1 , 2005, The British journal of dermatology.
[186] L. Kluwe,et al. Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene. , 2005, Anticancer research.
[187] Wendy Thomson,et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. , 2005, Arthritis and rheumatism.
[188] J. Kros,et al. Familial occurrence of tumours of the choroid plexus. , 1991, Journal of medical genetics.
[189] Ziv M. Williams,et al. Value of PET in the assessment of patients with neurofibromatosis type 1. , 2007, AJR. American journal of roentgenology.
[190] L. Rorke,et al. Leptomeningeal dissemination of low‐grade gliomas in childhood , 1988, Neurology.
[191] M. Walker,et al. Choroid plexus papilloma and cysts in the Aicardi syndrome: case reports. , 1997, Pediatric neurosurgery.
[192] W. J. Oakes,et al. Leptomeningeal dissemination of optic pathway gliomas in three children. , 1991, American journal of ophthalmology.
[193] P. Cogen,et al. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas , 1996, Genes, chromosomes & cancer.
[194] J. Epstein,et al. The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice. , 2006, The Journal of clinical investigation.
[195] R. Schmelzle,et al. Resection of small plexiform neurofibromas in neurofibromatosis type 1 children , 2005, World journal of surgical oncology.
[196] M. Nöthen,et al. Mutational analysis of TSC1 and TSC2 genes in gangliogliomas , 2001, Neuropathology and applied neurobiology.
[197] Denis Lacombe,et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[198] I. Pollack,et al. Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology. , 1995, Neurosurgery.
[199] D. Cooper,et al. Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1 , 2002, Human Genetics.
[200] M. Stratton,et al. Cytogenetic abnormalities in human ependymomas , 1989, International journal of cancer.
[201] B. Pollock,et al. Childhood cancer in the united states: A geographical analysis of cases from the Pediatric Cooperative Clinical Trials Groups , 1996, Cancer.
[202] P. Peltomäki,et al. HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1 , 2004, Genes, chromosomes & cancer.
[203] D. Louis Collins,et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.
[204] F. Chabolle,et al. Radiofrequency in the Treatment of Craniofacial Plexiform Neurofibromatosis: A Pilot Study , 2006, Plastic and reconstructive surgery.
[205] E. Zackai,et al. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6‐year follow‐up , 1995, Cancer.
[206] T. Poggio,et al. Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.
[207] I. Pollack. The Role of Surgery in Pediatric Gliomas , 1999, Journal of Neuro-Oncology.
[208] J. Biegel,et al. Monosomy 22 in rhabdoid or atypical tumors of the brain. , 1990, Journal of neurosurgery.
[209] M. Thom,et al. Mixed glioneuronal tumour of the fourth ventricle with prominent rosette formation , 2006, Neuropathology and applied neurobiology.
[210] J. Hirsch,et al. Benign astrocytic and oligodendrocytic tumors of the cerebral hemispheres in children. , 1989, Journal of neurosurgery.
[211] W Budach,et al. Radiation induced CNS toxicity – molecular and cellular mechanisms , 2001, British Journal of Cancer.
[212] Audrey E. Evans,et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial , 1989, Journal of Neuro-Oncology.
[213] M. Bergmann,et al. Dysembryoplastic neuroepithelial tumour of the cerebellum , 2004, Acta Neuropathologica.
[214] J Boyett,et al. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. , 1993, Neurosurgery.
[215] B. O'neill,et al. Phase II trial of pirfenidone in adults with neurofibromatosis type 1 , 2006, Neurology.
[216] R. McLendon,et al. Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. , 2008, Archives of pathology & laboratory medicine.
[217] T. Tamiya,et al. Ganglioglioma in a patient with Turcot syndrome. Case report. , 2000, Journal of neurosurgery.
[218] R. Prayson,et al. Glioneuronal tumor with neuropil-like islands. , 2000, Human pathology.
[219] AB Trovó‐Marqui,et al. Neurofibromin: a general outlook , 2006, Clinical genetics.
[220] P. Bey,et al. [An exceptional variety of medulloblastoma: melanotic medulloblastoma]. , 1997, Annales de pathologie.
[221] R. Arceci,et al. Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[222] K. Hoang-Xuan,et al. Glioblastomas with an Oligodendroglial Component: A Pathological and Molecular Study , 2001, Journal of neuropathology and experimental neurology.
[223] E. Levy-Lahad,et al. Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1. , 2006, Human reproduction.
[224] D. Viskochil,et al. Molecular, Genetic, and Cellular Pathogenesis of Neurofibromas and Surgical Implications , 2006, Neurosurgery.
[225] J. Hoffman. New advances in brain tumor imaging , 2001, Current opinion in oncology.
[226] C. Roberts,et al. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[227] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[228] D. Coviello,et al. The Genoa experience of prenatal diagnosis in NF1 , 2000, Prenatal diagnosis.
[229] L. Palma,et al. Hemispheric supratentorial astrocytomas in children. Long-term results in 29 cases. , 1981, Journal of neurosurgery.
[230] P. Kelly,et al. Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.
[231] W. Halliday,et al. Thalamic tumors in children. Long-term follow-up and treatment guidelines. , 1984, Journal of neurosurgery.
[232] M. Yaniv,et al. When the SWI/SNF complex remodels … the cell cycle , 2001, Oncogene.
[233] M. Bilsky,et al. A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including "rosetted") islands: report of 4 cases. , 1999, The American journal of surgical pathology.
[234] H. Bloom,et al. The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950-1981. , 1990, International journal of radiation oncology, biology, physics.
[235] I. Pollack,et al. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. , 1995, Journal of neurosurgery.
[236] O. G. Dodge,et al. Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.
[237] J. Reisch,et al. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[238] A. Perry,et al. Spindle Cell Oncocytoma of the Adenohypophysis: Report of Two Recurrent Cases , 2005, The American journal of surgical pathology.
[239] J. Biegel,et al. Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor , 1992, Genes, chromosomes & cancer.
[240] R. Hughes,et al. Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1 , 2000, Journal of neurology, neurosurgery, and psychiatry.
[241] M. Berger,et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. , 1998, Journal of neurosurgery.
[242] D. Ellison,et al. Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. , 2002, The American journal of pathology.
[243] J. Montes,et al. Low-grade astrocytomas in children: evolving management strategies. , 1998, International journal of radiation oncology, biology, physics.
[244] Douglas C. Miller,et al. Deferring adjuvant therapy for totally resected intracranial ependymoma. , 1996, Pediatric neurology.
[245] M. Maeda,et al. Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI , 2009, Journal of Cancer Research and Clinical Oncology.
[246] B. Korf,et al. Superficial neurofibroma: a lesion with unique MRI characteristics in patients with neurofibromatosis type 1. , 2005, AJR. American journal of roentgenology.
[247] Webster K. Cavenee,et al. Pathology and genetics of tumours of the nervous system. , 2000 .
[248] M. Clementi,et al. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. , 2007, Neuro-oncology.
[249] A. Sands,et al. Disruption of Ini1 Leads to Peri-Implantation Lethality and Tumorigenesis in Mice , 2001, Molecular and Cellular Biology.
[250] S. Pomeroy,et al. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[251] R. Packer,et al. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[252] T. Merchant,et al. Bithalamic Involvement Predicts Poor Outcome among Children with Thalamic Glial Tumors , 1998, Pediatric Neurosurgery.
[253] E. López-Aguilar,et al. Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children , 2003, Child's Nervous System.
[254] P F Morrison,et al. Convection-enhanced delivery of macromolecules in the brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[255] K. Keyvani,et al. Rosetted glioneuronal tumor: a case with proliferating neuronal nodules , 2001, Acta Neuropathologica.
[256] D. Frappaz,et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.